13FPulse
中
EW

EWTX EDGEWISE THERAPEUTICS INC

2026Q2 · CUSIP 28036F105 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
223
Institutions that reported holding it to the SEC
Net increase in holders
+10
Last quarter 213 → now 223
How unusual is that
Above average
Stronger buying than 69% of US stocks
What the filings say, in one paragraph

223 funds held EWTX at the end of 2026Q2, up 10 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, return on equity is -44.0%. EWTX has had 6 buying rushes in its history, and the price moved -6.7% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2021Q2: holders=45 2021Q3: holders=47 2021Q4: holders=57 2022Q1: holders=71 2022Q2: holders=78 2022Q3: holders=95 2022Q4: holders=91 2023Q1: holders=85 2023Q2: holders=95 2023Q3: holders=85 2023Q4: holders=116 2024Q1: holders=129 2024Q2: holders=140 2024Q3: holders=176 2024Q4: holders=200 2025Q1: holders=191 2025Q2: holders=177 2025Q3: holders=172 2025Q4: holders=197 2026Q1: holders=213 2026Q2: holders=223 -36 -18 +0 +18 +36 40138235 21Q221Q422Q222Q423Q223Q424Q224Q425Q225Q426Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 6 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2024Q3 Top 10% -12.1% -54.5%
2023Q4 Top 20% +4.3% +8.3%
2022Q3 Top 10% +7.0% -8.1%
2022Q2 Top 20% -1.8% -6.4%
2022Q1 Top 20% +48.1% +37.5%
2021Q2 Top 20% +27.5% -17.1%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
123
Change in large funds
+14
Total value they hold
$4.8B
Funds buying for the first time
42
Funds that sold out entirely
32
Price change that quarter
+31.7%
Funds holding puts (bearish)
4
Funds holding calls (bullish)
5

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.85
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-44.0%
Debt ratio
6.6%
FCF (TTM)
-$159M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.26 2021-12-31: EPS 3.70 2022-03-31: EPS -0.30 2022-06-30: EPS -0.32 2022-09-30: EPS -0.34 2022-12-31: EPS -0.30 2023-03-31: EPS -0.36 2023-06-30: EPS -0.34 2023-09-30: EPS -0.41 2023-12-31: EPS -0.46 2024-03-31: EPS -0.33 2024-06-30: EPS -0.34 2024-09-30: EPS -0.36 2024-12-31: EPS -0.42 2025-03-31: EPS -0.43 2025-06-30: EPS -0.34 2025-09-30: EPS -0.39 2025-12-31: EPS -0.47 2026-03-31: EPS -0.46 2026-06-30: EPS -0.53 -0.58 1.74 4.07 20212022202320242025202606/26 EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
3 4 4 20222023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-43M-21M0K 2020202120222023202420252026
Latest quarter $-43M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.